Literature DB >> 10544305

A mixed effects model for the analysis of repeated measures cross-over studies.

M Putt1, V M Chinchilli.   

Abstract

A mixed effects model is developed for cross-over trials in which the response is measured repeatedly within each time period. Relative to previous work on repeated measures cross-overs, the methodology synthesizes two important features. First, our procedure eliminates preliminary testing for carry-over, defined loosely as the component of a response that is due to treatment in the preceding period. This is achieved by generalizing the methodology to cross-over designs in which preliminary testing for carry-over is unnecessary. We focus largely on 'simple' carry-over, that is, carry-over that lasts for exactly one period and is independent of the treatment administered in the period in which the carry-over occurs. However, we also illustrate a modification of the procedure for a repeated measures cross-over design which uses a more complicated model of carry-over. Second, the model allows both the between- and within-subject variance to differ among treatments. Conditions are described wherein closed-form (CF) solutions to the variance components as well as closed-form hypothesis tests of the treatment differences exist. Flexibility in the model is illustrated with an example in which inference based on the CF likelihood-based estimates of the variance, and estimates formed using an iterative routine (PROC MIXED) are compared. Copyright 1999 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  1999        PMID: 10544305     DOI: 10.1002/(sici)1097-0258(19991130)18:22<3037::aid-sim243>3.0.co;2-7

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  8 in total

1.  A matched crossover design for clinical trials.

Authors:  Laura J Simon; Vernon M Chinchilli
Journal:  Contemp Clin Trials       Date:  2007-02-27       Impact factor: 2.226

2.  Investigation of the predictive validity of laser-EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteers.

Authors:  Klaus Schaffler; Laurent B Nicolas; Andreas Borta; Tobias Brand; Peter Reitmeir; Robert Roebling; Joachim Scholpp
Journal:  Br J Clin Pharmacol       Date:  2017-02-27       Impact factor: 4.335

3.  Comfort and exertion while using filtering facepiece respirators with exhalation valve and an active venting system among male military personnel.

Authors:  Melvin Seng; Liang En Wee; Xiahong Zhao; Alex R Cook; Sin Eng Chia; Vernon J Lee
Journal:  Singapore Med J       Date:  2017-07-06       Impact factor: 1.858

4.  Plasticity, permanence, and patient performance: study design and data analysis in the cognitive rehabilitation of acquired communication impairments.

Authors:  Patricia E Cowell; Sandra P Whiteside; Fay Windsor; Rosemary A Varley
Journal:  Front Hum Neurosci       Date:  2010-11-26       Impact factor: 3.169

5.  Thoracic spine thrust manipulation for individuals with cervicogenic headache: a crossover randomized clinical trial.

Authors:  Amy W McDevitt; Joshua A Cleland; Daniel I Rhon; Rebecca A K Altic; Drew J Courtney; Paul E Glynn; Paul E Mintken
Journal:  J Man Manip Ther       Date:  2021-07-16

6.  The effect of nocturnal wear of complete dentures on sleep and oral health related quality of life: study protocol for a randomized controlled trial.

Authors:  Elham Emami; Phan The Huy Nguyen; Fernanda R Almeida; Jocelyne S Feine; Igor Karp; Gilles Lavigne; Nelly Huynh
Journal:  Trials       Date:  2014-09-13       Impact factor: 2.279

7.  Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study.

Authors:  S R T Veerman; P F J Schulte; J D Smith; L de Haan
Journal:  Psychol Med       Date:  2016-04-06       Impact factor: 7.723

8.  Effect of music (Brahms lullaby) and non-nutritive sucking on heel lance in preterm infants: A randomized controlled crossover trial.

Authors:  Hiroko Uematsu; Ikuko Sobue
Journal:  Paediatr Child Health       Date:  2018-07-24       Impact factor: 2.253

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.